New cephalosporin FDA approved

The FDA approved ceftaroline (Teflaro) for CAP and complicated SSSI, including those caused by MRSA. In 3 large trials, it was shown to be equivalent to vancomycin/aztreonam (for SSSIs) and ceftriaxone (for CAP) (FDA site)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment